Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Bio
Professional summary
Jake Simson is a Partner at RA Capital Management, where he works across public and private investments. RA Capital lists him as a board director for Bicara Therapeutics, Convergent Therapeutics, Janux Therapeutics, Outpace Bio, Septerna, Tyra Biosciences, and Vivace Bio. The firm also states that he previously covered solid tumor oncology landscapes. His doctoral research focused on clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels. He holds a BS in Materials Science and Engineering from MIT and a PhD in Biomedical Engineering from Johns Hopkins University.
Investment focus
Stage, sector, and overall fit
Stage
public healthcare companiesprivate healthcare companies
Sector
biotechnologylife sciencesoncologytherapeuticsmusculoskeletal repair
Thesis
Public and private healthcare and life sciences investmentsSolid tumor oncology landscapesTherapeutics and biotech platforms
Notable companies
Selected portfolio companies the partner has backed
Bicara TherapeuticsConvergent TherapeuticsJanux TherapeuticsOutpace BioSepternaTyra BiosciencesVivace Bio
How to approach
Framing and angles for outreach
Pitch framing
Relevant for biotech founders with strong translational science, oncology relevance, or platform therapeutics angles.
Personalization hooks
- 1Mention his board involvement with multiple clinical and platform biotechnology companies.
- 2For oncology companies, connect the discussion to his prior solid tumor oncology landscape work.
Background
Career, education, and skills
Career history
- RA Capital ManagementPartner
Education
- The Johns Hopkins UniversityPh.D., Life Sciences (inferred)
Skills
Biotech investingTherapeuticsHealthcare M&A researchFDA policy
Other partners at RA Capital Management
12 more profiles
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.